Growing Arizona Company PathogenDx Expands Staff and Footprint
Growing Arizona Company PathogenDx Expands Staff and Footprint

PathogenDx, Inc., the Arizona based technology company, which provides a DNA-based customized pathogen testing platform for the cannabis industry, announced today that over the past two months it has expanded key staff by...

Statement from FDA Commissioner Scott Gottlieb, M.D., on additional steps by the agency to support the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes
Statement from FDA Commissioner Scott Gottlieb, M.D., on additional steps by the agency to support the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes

More than 54 years after the landmark Surgeon General's report on smoking and health, tobacco use – primarily cigarette smoking – remains the leading cause of preventable disease and death in the U.S., responsible for...

BPSA Releases Guide to Production of Cell and Gene Therapies
BPSA Releases Guide to Production of Cell and Gene Therapies

The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest white paper, The Role of Single-Use Polymeric Solutions in...

7th Annual Chief Medical Officer Summit Announced by The Conference Forum
7th Annual Chief Medical Officer Summit Announced by The Conference Forum

The Conference Forum is pleased to announce the launch of the 7th Annual Chief Medical Officer Summit for the biotech industry on April 4-5, 2019 at the Hilton Boston Back Bay Hotel, Boston, Massachusetts. The CMO Summit...

FDA advances new proposed regulation to make sure that sunscreens are safe and effective
FDA advances new proposed regulation to make sure that sunscreens are safe and effective

The U.S. Food and Drug Administration today issued a proposed rule that would update regulatory requirements for most sunscreen products in the United States.

Arterez Introduces a Novel, Triple-Compound Oral Therapy and Diagnostic Panels Targeting The Multi-Factorial 'Root-Causes' of Cardiovascular Disease - Not Cholesterol - in Human Studies
Arterez Introduces a Novel, Triple-Compound Oral Therapy and Diagnostic Panels Targeting The Multi-Factorial 'Root-Causes' of Cardiovascular Disease - Not Cholesterol - in Human Studies

Cardiovascular disease (CVD), particularly coronary heart disease (CHD), remains the No. 1 disease killer and continues to rise in the US and the world despite record numbers of statins being prescribed year after year....

Grace Therapeutics to Present at the Cowen 39th Annual Healthcare Conference
Grace Therapeutics to Present at the Cowen 39th Annual Healthcare Conference

Grace Therapeutics, a clinical stage biopharmaceutical company focused on rare and orphan diseases, announced today that it is scheduled to speak at the Cowen Healthcare Conference in Boston.

Theravance Biopharma to Present at the 8th Annual SVB Leerink Global Healthcare Conference
Theravance Biopharma to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that management will participate in a fireside chat at the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019, at 9:00 a.m. ET. The...

Intrexon to Announce Fourth Quarter 2018 Financial Results on February 28th
Intrexon to Announce Fourth Quarter 2018 Financial Results on February 28th

Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced it will release fourth quarter 2018 financial...

Base Pair Biotechnologies Announces Fast Track SBIR Grant Award from National Institutes of Health
Base Pair Biotechnologies Announces Fast Track SBIR Grant Award from National Institutes of Health

Base Pair Biotechnologies, Inc., the Aptamer Discovery Company™, announced today the receipt of a Fast Track Small Business Innovation Research grant from the National Institute on Drug Abuse of the National Institutes of...

Audentes Therapeutics to Release Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update on Wednesday, February 27, 2019
Audentes Therapeutics to Release Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update on Wednesday, February 27, 2019

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, will host a...

Ardelyx to Participate in Leerink Partners 8th Annual Global Healthcare Conference
Ardelyx to Participate in Leerink Partners 8th Annual Global Healthcare Conference

Ardelyx, Inc. (NASDAQ: ARDX) today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a fireside chat at the Leerink Partners Global Healthcare Conference at 2:30 p.m. ET on...

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its fourth quarter and year end 2018 financial results after market close on Thursday, February 28, 2019.  Rigel senior management will follow...

Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies
Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies

Geneos Therapeutics announced today that it has closed its Series A round raising $10.5 Million in financing.  This funding will launch its operations as a standalone entity to develop the next generation of...

Terramera secures USD $10 million in financing from BDC
Terramera secures USD $10 million in financing from BDC

Investment will help Vancouver-based cleantech firm commercialize technologies that promise to revolutionize agriculture

Protagonist Therapeutics to Present at the Leerink Partners 8th Annual Global Healthcare Conference on Thursday, Feb. 28
Protagonist Therapeutics to Present at the Leerink Partners 8th Annual Global Healthcare Conference on Thursday, Feb. 28

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will provide a corporate overview at the Leerink Partners 8th Annual Global Healthcare...

Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer
Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer

Enzyvant, a biopharmaceutical company focused on developing transformative therapies for patients with rare diseases, today announced the appointment of Rachelle Jacques as Chief Executive Officer.

Denovo Biopharma Announces New Hires for Positions of Chief Medical Officer of Hematology and Senior Vice President, Regulatory Affairs and Quality Assurance
Denovo Biopharma Announces New Hires for Positions of Chief Medical Officer of Hematology and Senior Vice President, Regulatory Affairs and Quality Assurance

Denovo Biopharma, a leader in precision medicine, today announced the hiring of two senior executives, reporting to the CEO: Lei Zhang, MD, as Chief Medical Officer, Hematology, and Bruce M. Wagman, as Senior Vice...

Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.
Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced it has extended its collaboration with The Wistar Institute and Dmitry I....

New PhRMA Report Finds 130 Medicines in Development for Asthma, Allergies and Other Respiratory Diseases
New PhRMA Report Finds 130 Medicines in Development for Asthma, Allergies and Other Respiratory Diseases

Millions of Americans suffer from respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). Together, these two diseases affect the day-to-day lives of over 40 million patients in the United...

Apheresis Market to hit US$4.33 Billion by 2025, Says TMR
Apheresis Market to hit US$4.33 Billion by 2025, Says TMR

According to the research report by TMR, the global apheresis market was valued at US$1.85 bn in 2016 and is projected to expand at a CAGR of 10.2% from 2017 to 2025. Based on procedure, the donor or automated apheresis is...

Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today the topline results of FP-001 LMIS (Leuprolide Mesylate Injectable Suspension) 25 mg phase 3 clinical trial, an open-label, single-arm study in...

SpineFrontier's® First SacroFUSE® and NanoFUSE Case Performed in Latin America
SpineFrontier's® First SacroFUSE® and NanoFUSE Case Performed in Latin America

On January 7th, 2019, Neurosurgeons Dr. Mario Cahueque and Dr. Enrique Azmitia implanted SpineFrontier's SacroFuse system in conjunction with NanoFUSE's Orthobiologic during a surgery at the Hospital Centro Medico...

Rigaku Presents Latest XRM and CT Technology at 2019 TSM Meeting
Rigaku Presents Latest XRM and CT Technology at 2019 TSM Meeting

X-ray analytical instrument manufacturer Rigaku Corporation is pleased to announce its attendance at the 54th annual meeting of the Texas Society for Microscopy (TSM). The event is hosted by the Kleberg Advanced Microscopy...

Fiberstar, Inc. Announces a Clean and Novel Way to Replace Phosphates in Meat and Poultry
Fiberstar, Inc. Announces a Clean and Novel Way to Replace Phosphates in Meat and Poultry

Clean label food is not just another passing trend in the limelight. This fast-growing movement is now expected when creating natural foods and beverages. It is quite common to spot consumers running their index finger...

Satsuma Pharmaceuticals Provides Corporate Update and Prepares to Advance Lead Product Candidate, STS101, Into Phase 3 Efficacy Trial for Acute Migraine
Satsuma Pharmaceuticals Provides Corporate Update and Prepares to Advance Lead Product Candidate, STS101, Into Phase 3 Efficacy Trial for Acute Migraine

Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a clinical-stage biopharmaceutical company, today provided a corporate update, including recent progress with its development of STS101 for the acute treatment of...

Rhode Island Headlines 

Massachusetts Headlines 

National